University of Bologna
Anti-inflammatory compounds in middle age may decrease CV events in aging
Published in Physician Law Weekly, December 8th, 2004
Investigators in Italy report, "Genetic background of inflammatory or anti-inflammatory molecules may be helpful in identifying subjects with increased or decrease risk of developing cardiovascular disease. Bi-allele polymorphism (C>T) in the promoter region (-511) of the interleukin-1beta (IL-1beta) gene and the bi-allele polymorphism (G>C) in the promoter region (-174) of interleukin-6 (IL-6) gene were determined in elderly men patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2004-12-08)
More Articles from Physician Law Weekly
- Abbott Laboratories
Pharmaceutical's former employees challenge benefits move in division spin-off - California Department of Social Services
California social services announces 'surrendered baby' awareness campaign - Complementary & Alternative Medicine
Tennessee Senator plans to make legal medical marijuana a top priority - CryoLife, Inc.
Biosurgical-device company reports settlement of cases - Endocare, Inc.
Ablation and vacuum-technology company resolves class-action litigation - Food Safety
Law requiring country of origin to be on food labels may be repealed - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
